Form D · Other Health Care

Pulse Biosciences, Inc.

Hayward, CA · CIK 0001625101

Offering snapshot reported Jul 9, 2021 · SEC filing

Reported sold
$50M
Offering amount: $50M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 9, 2021Initial$50,000,000No comparisonNot reportedSEC filing
Sep 28, 2017Initial$30,040,000No comparison1SEC filing
Feb 15, 2017Initial$5,000,005No comparison2SEC filing
Nov 13, 2014Initial$7,999,997No comparison72SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-405734

Source: Form D, filed Jul 9, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kenneth Clark Director
Brian B. Dow Executive
Robert Duggan Director
Edward Ebbers Executive
Sandra Gardiner Executive
Robert J. Greenberg Director
Robert Levande Director
Mitchell Levinson Director
Christopher Marlett Director
Manmeet Soni Director
Thierry B. Thaure Director
Darrin Uecker Director, Executive
Richard Van Den Broek Director
Amy Wang Director, Executive
Mahkam Zanganeh Director
Maky Zanganeh Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
3957 Point Eden Way
Hayward, CA, 94545